The intestinal permeability marker FITC-dextran 4kDa should be dosed according to lean body mass in obese mice
Abstract Aims To investigate the influence of the dose in the FITC-Dextran 4kDa (FD-4) permeability test in an obese mouse model, we tested the bodyweight dose regimen and a lean body mass-based dose regimen in high fat diet (HFD) mice and low fat diet (LFD) mice. We hypothesized that the FD-4 perme...
Main Authors: | Louise M. Voetmann, Bidda Rolin, Rikke K. Kirk, Charles Pyke, Axel K. Hansen |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-01-01
|
Series: | Nutrition & Diabetes |
Online Access: | https://doi.org/10.1038/s41387-022-00230-2 |
Similar Items
-
FITC-Dextran Release from Cell-Embedded Fibrin Hydrogels
by: Viki Raz Lepsky, et al.
Published: (2021-02-01) -
Transdermal delivery of FITC-Dextrans with different molecular weights using radiofrequency microporation
by: Guk Young Ahn, et al.
Published: (2020-12-01) -
Behaviour of FITC-Labeled Polyallylamine in Polyelectrolyte Microcapsules
by: Alexey V. Dubrovskii, et al.
Published: (2023-08-01) -
Diagnosis of Anti-Angiogenesis Peptide Binding to HUVECs Using FITC
by: M Shourian, et al.
Published: (2019-09-01) -
Sustainable Synthesis of FITC Chitosan-Capped Gold Nanoparticles for Biomedical Applications
by: Valeria De Matteis, et al.
Published: (2022-09-01)